Skip to content
ppharmaranks
Menu

TRADJENTA vs ZITUVIO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. TRADJENTA and ZITUVIO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

72/100
New

Pharmacy pays

~$110.51 /30

Type

RX
RX

Active ingredient

LINAGLIPTIN
SITAGLIPTIN

Dosage forms

Tablet
Tablet

Drug class

Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitor

Boxed warning

None
None

Half-life

about 200 hours — the terminal (elimination) half-life at steady state, per the label
about 12.4 hours (apparent terminal half-life after a single 100 mg oral dose in healthy volunteers)

Treats

Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus

Get tradjentahigher-rated option

Advertising disclosure: Some links are affiliate links. We may earn a commission at no extra cost to you. This never affects our independent ratings.

Get treatment online

Licensed online providers — consult & get prescribed if eligible.

Frequently asked questions

What is the difference between Tradjenta and Zituvio?

Tradjenta contains Linagliptin, while Zituvio contains Sitagliptin — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.